Certified by Founder Lodge
TISSIUM
France - Paris, Ile-de-France
START UP
1 Disclosed Funding Rounds $50,000,000
0 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 23 ,2023 | Series D | $50,000,000 |
Cathay Health
Sofinnova Partners
Crédit Mutuel Innovation
Moon Surgical
Centerline Biomedical
Cara Care
De Oro Devices
Luminate Medical
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
